Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04116957 · ClinicalTrials.gov registry record · NA

RTLS for Healthcare Process Validation

A NA study, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT04116957: Completed NA study, sponsored by University of Missouri-Columbia.

NCT04116957 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04116957, a NA study, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The purpose of the project is to develop a new way to understand patient care data analytics by using a real-time location system (RTLS). The investigators will deploy the RTLS-based nursing activity analysis system at an ICU at the University Hospital, University of Missouri Health Care in Columbia, Missouri. The investigators will validate location system performance against manual observation of nursing activity. The investigators will correlate nursing activity metrics against patient outcomes as measured by SOFA score.

Primary Outcome

To compare the time difference between the RTLS system and manual observation data, all In-Room activity times collected from the RTLS system are statistically compared to the In-Room activity time collected from the time study data done by observers. A paired t-test is used to determine whether the means of the two groups are statistically different from each other. The anticipated outcome is actionable, location-based data to describe, analyze, or validate healthcare processes with a maximum e

Interventions

  • DEVICE RTLS current tag
  • DEVICE RTLS tag revised

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2020-02-17
Est. Completion 2021-05-31
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT04116957 record still lists

NCT04116957 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which RTLS current tag is the first listed.

NCT04116957 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04116957 about?

NCT04116957 is a clinical study titled "RTLS for Healthcare Process Validation". The purpose of the project is to develop a new way to understand patient care data analytics by using a real-time location system (RTLS). The investigators will deploy the RTLS-based nursing activity analysis system at an ICU at the University Hospital, University of Missouri Health Care in Columbia...

What is the current status of trial NCT04116957?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2020-02-17. Estimated completion is 2021-05-31.

What interventions are being tested in trial NCT04116957?

The interventions under investigation include: RTLS current tag (DEVICE), RTLS tag revised (DEVICE).

Who is sponsoring clinical trial NCT04116957?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04116957's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04116957, the US trial registry maintained by the National Library of Medicine. NCT04116957 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.